mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.5 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |